170 related articles for article (PubMed ID: 15231765)
21. Staphylococcal multidrug efflux protein QacA.
Brown MH; Skurray RA
J Mol Microbiol Biotechnol; 2001 Apr; 3(2):163-70. PubMed ID: 11321569
[TBL] [Abstract][Full Text] [Related]
22. Phenotypic changes in ciprofloxacin-resistant Staphylococcus aureus.
Mesak LR; Davies J
Res Microbiol; 2009 Dec; 160(10):785-91. PubMed ID: 19818400
[TBL] [Abstract][Full Text] [Related]
23. Production of the cryptic EefABC efflux pump in Enterobacter aerogenes chloramphenicol-resistant mutants.
Masi M; Pagès JM; Pradel E
J Antimicrob Chemother; 2006 Jun; 57(6):1223-6. PubMed ID: 16606635
[TBL] [Abstract][Full Text] [Related]
24. Multidrug efflux pump overexpression in Staphylococcus aureus after single and multiple in vitro exposures to biocides and dyes.
Huet AA; Raygada JL; Mendiratta K; Seo SM; Kaatz GW
Microbiology (Reading); 2008 Oct; 154(Pt 10):3144-3153. PubMed ID: 18832320
[TBL] [Abstract][Full Text] [Related]
25. Characterization of NorR protein, a multifunctional regulator of norA expression in Staphylococcus aureus.
Truong-Bolduc QC; Zhang X; Hooper DC
J Bacteriol; 2003 May; 185(10):3127-38. PubMed ID: 12730173
[TBL] [Abstract][Full Text] [Related]
26. Inducible NorA-mediated multidrug resistance in Staphylococcus aureus.
Kaatz GW; Seo SM
Antimicrob Agents Chemother; 1995 Dec; 39(12):2650-5. PubMed ID: 8592996
[TBL] [Abstract][Full Text] [Related]
27. Discovery of novel inhibitors of the NorA multidrug transporter of Staphylococcus aureus.
Brincat JP; Carosati E; Sabatini S; Manfroni G; Fravolini A; Raygada JL; Patel D; Kaatz GW; Cruciani G
J Med Chem; 2011 Jan; 54(1):354-65. PubMed ID: 21141825
[TBL] [Abstract][Full Text] [Related]
28. Altered gene expression in the transition phase by disruption of a Na+/H+ antiporter gene (shaA) in Bacillus subtilis.
Kosono S; Asai K; Sadaie Y; Kudo T
FEMS Microbiol Lett; 2004 Mar; 232(1):93-9. PubMed ID: 15019740
[TBL] [Abstract][Full Text] [Related]
29. Piperine analogs as potent Staphylococcus aureus NorA efflux pump inhibitors.
Sangwan PL; Koul JL; Koul S; Reddy MV; Thota N; Khan IA; Kumar A; Kalia NP; Qazi GN
Bioorg Med Chem; 2008 Nov; 16(22):9847-57. PubMed ID: 18848780
[TBL] [Abstract][Full Text] [Related]
30. The role of the qacA gene in mediating resistance to quaternary ammonium compounds.
Cervinkova D; Babak V; Marosevic D; Kubikova I; Jaglic Z
Microb Drug Resist; 2013 Jun; 19(3):160-7. PubMed ID: 23256651
[TBL] [Abstract][Full Text] [Related]
31. Salicylate decreases production of AmpC type beta-lactamases and increases susceptibility to beta-lactams in a Morganella morganii clinical isolate.
Tavío MM; Perilli M; Vila J; Becerro P; Casañas L; Amicosante G; Jiménez de Anta MT
FEMS Microbiol Lett; 2004 Sep; 238(1):139-44. PubMed ID: 15336414
[TBL] [Abstract][Full Text] [Related]
32. Efflux-related resistance to norfloxacin, dyes, and biocides in bloodstream isolates of Staphylococcus aureus.
DeMarco CE; Cushing LA; Frempong-Manso E; Seo SM; Jaravaza TA; Kaatz GW
Antimicrob Agents Chemother; 2007 Sep; 51(9):3235-9. PubMed ID: 17576828
[TBL] [Abstract][Full Text] [Related]
33. Altered spectrum of multidrug resistance associated with a single point mutation in the Escherichia coli RND-type MDR efflux pump YhiV (MdtF).
Bohnert JA; Schuster S; Fähnrich E; Trittler R; Kern WV
J Antimicrob Chemother; 2007 Jun; 59(6):1216-22. PubMed ID: 17062614
[TBL] [Abstract][Full Text] [Related]
34. The 5' untranslated region of fruA mRNA is required for translational enhancement of FruA synthesis during Myxococcus xanthus development.
Ding N; Zheng Y; Wu Q; Mao X
Arch Microbiol; 2008 Mar; 189(3):279-88. PubMed ID: 17992513
[TBL] [Abstract][Full Text] [Related]
35. LadR, a new PadR-related transcriptional regulator from Listeria monocytogenes, negatively regulates the expression of the multidrug efflux pump MdrL.
Huillet E; Velge P; Vallaeys T; Pardon P
FEMS Microbiol Lett; 2006 Jan; 254(1):87-94. PubMed ID: 16451184
[TBL] [Abstract][Full Text] [Related]
36. MepR, a repressor of the Staphylococcus aureus MATE family multidrug efflux pump MepA, is a substrate-responsive regulatory protein.
Kaatz GW; DeMarco CE; Seo SM
Antimicrob Agents Chemother; 2006 Apr; 50(4):1276-81. PubMed ID: 16569840
[TBL] [Abstract][Full Text] [Related]
37. A novel type I toxin-antitoxin system modulates persister cell formation in Staphylococcus aureus.
Habib G; Zhu J; Sun B
Int J Med Microbiol; 2020 Feb; 310(2):151400. PubMed ID: 32001143
[TBL] [Abstract][Full Text] [Related]
38. A mutation in the 5' untranslated region increases stability of norA mRNA, encoding a multidrug resistance transporter of Staphylococcus aureus.
Fournier B; Truong-Bolduc QC; Zhang X; Hooper DC
J Bacteriol; 2001 Apr; 183(7):2367-71. PubMed ID: 11244079
[TBL] [Abstract][Full Text] [Related]
39. Coordinated and differential control of aureolysin (aur) and serine protease (sspA) transcription in Staphylococcus aureus by sarA, rot and agr (RNAIII).
Oscarsson J; Tegmark-Wisell K; Arvidson S
Int J Med Microbiol; 2006 Oct; 296(6):365-80. PubMed ID: 16782403
[TBL] [Abstract][Full Text] [Related]
40. The cme gene of Clostridium difficile confers multidrug resistance in Enterococcus faecalis.
Lebel S; Bouttier S; Lambert T
FEMS Microbiol Lett; 2004 Sep; 238(1):93-100. PubMed ID: 15336408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
